Dallas – October 13, 2026 -- Koya Medical will put its CEO and CFO in front of investors at two conferences on consecutive days, October 19 and 20, 2026, as the vascular disease device maker promotes the commercial momentum of its portfolio.
CEO Doraiswamy presents at Goldman Sachs in New York on October 19
Andy Doraiswamy, Koya's chief executive, will present on Monday, October 19, 2026, at the Goldman Sachs Healthcare Private Company Conference. The session takes place at the Goldman Sachs Client Center in New York City.
CFO Rippole takes the Bank of America stage in Boston on October 20
Damian Rippole, the company's chief financial officer, will present on Tuesday, October 20, 2026, at The MedTech Conference hosted by AdvaMed. His slot is part of the Bank of America Company Presentations, held in Room 050 at the Thomas M. Menino Convention & Exhibition Center in Boston.
Dayspring compression therapy anchors the commercial pitch
Both executives plan to discuss commercial momentum for Koya's vascular portfolio, including Dayspring, a non-pneumatic compression treatment for chronic edema. They will also update investors on the company's vascular pipeline and ongoing clinical research.
Koya did not disclose revenue, funding or other financial metrics in its announcement.